Physician profile
Angela A Ganan Popa
NPI 1093004079
$62,381.83
in general payments reported to CMS, 2019-2025
13 companies · $42K in 2025
The $42K reported for 2025 was more than what 96% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2021: $42.00 · 2023: $386 · 2024: $20K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58K · Food and Beverage: $2,712 · Travel and Lodging: $1,797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $57,654.50 |
| Food and Beverage | $2,711.99 |
| Travel and Lodging | $1,796.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $61,545.09 | 2024-2025 | |
| Insulet Corporation | $241.33 | 2019-2024 | Omnipod |
| Abbott Laboratories | $198.39 | 2019-2024 | Freestyle Libre 3 |
| Dexcom, INC. | $88.54 | 2023 | Dexcom G6 Transmitter |
| Eton Pharmaceuticals, INC. | $51.29 | 2023-2024 | Alkindi |
| Tandem Diabetes Care, INC. | $49.04 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Pfizer INC. | $45.06 | 2023-2025 | |
| Beta Bionics, INC. | $42.82 | 2023-2024 | Ilet Bionic Pancreas |
| Tolmar Pharmaceuticals, INC. | $42.00 | 2021 | |
| Kyowa Kirin, INC. | $25.33 | 2024 | Crysvita |
| Abbvie INC. | $21.73 | 2023 | |
| Novo Nordisk INC | $17.31 | 2024 | Sogroya |
| Ascensia Diabetes Care US INC. | $13.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Ganan Popa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.